Physician profile
Natchez Morice
NPI 1326022252
$5,773.32
in general payments reported to CMS, 2019-2025
10 companies · $1,580 in 2025
The $1,580 reported for 2025 was more than what 93% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $267 · 2020: $46.38 · 2021: $92.25 · 2022: $199 · 2023: $39.53 · 2024: $3,549 · 2025: $1,580.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,868 · Education: $1,500 · Food and Beverage: $792 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,867.50 |
| Education | $1,500.00 |
| Food and Beverage | $792.45 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,878.13 | 2024-2025 | |
| Abbvie INC. | $364.86 | 2019-2023 | |
| Mckesson Medical-Surgical, INC. | $171.11 | 2024 | |
| Roche Diagnostics Corporation | $129.43 | 2019 | |
| Hologic Sales and Service, LLC | $58.14 | 2021-2023 | Affirm Prone Biopsy System |
| Dexcom, INC. | $49.32 | 2025 | Dexcom G6 Transmitter |
| Coloplast Corp | $47.48 | 2019 | |
| Astellas Pharma US INC | $30.60 | 2025 | Veozah |
| Lupin INC. | $26.84 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $17.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natchez Morice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.